Use of a polyvalent bacterial lysate in patients with recurrent respiratory tract infections: Results of a prospective, placebo-controlled, randomized, double-blind study

Advances in Therapy

Volumn 15, Issue 6, 1998, Pages 330-341

  Rutishauser, Markus ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Bacterial lysate; Immunotherapy; Mucosa associated lymphoid tissue; Oral immunomodulator; Respiratory tract infections

Indexed keywords

BACTERIAL VACCINE; IMMUNOMODULATING AGENT; LUIVAC; LW 50020; PASPAT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL PNEUMONIA; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RECURRENT INFECTION; RHINITIS; TABLET FORMULATION;

ADJUVANTS, IMMUNOLOGIC; ADOLESCENT; ADULT; AGED; BACTERIAL VACCINES; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PLACEBOS; PROSPECTIVE STUDIES; RECURRENCE; RESPIRATORY TRACT INFECTIONS;

EID: 0032405930     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Van Daal GJ, de Jong FT, Mouton JW, et al. Oral immunization with bacterial lysate against infection with S. pneumoniae in mice. Respiration. 1990;57:229-232.
2. Van Daal GJ, Beusenberg FD, So KL, et al. Protection against influenza A virus infection in mice by oral immunization with a polyvalent bacterial lysate. Int J Immunopharmacol. 1991;7:831-840.
3. Ruedl C, Albin B, Böck G, Wick G, Wolf H. Oral administration of a bacterial immunomodulator enhances murine intestinal lamina propria and Peyer's patch lymphocyte traffic to the lung: possible implications for infectious disease prophylaxis and therapy. Intern Immunol. 1993;5:29-36.